GL Pharm Tech Corp. (KOSDAQ:204840)

GL Pharm Tech Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 12, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	85,304	75,097	70,834	46,578	76,699	68,455
Market Cap Growth	11.50%	6.02%	52.08%	-39.27%	12.04%	73.91%
Enterprise Value	100,355	82,885	82,845	55,794	82,225	76,787
Last Close Price	1100.00	977.00	1136.00	750.00	1240.00	1450.00
PS Ratio	2.49	2.88	2.72	2.78	6.17	5.71
PB Ratio	4.26	3.82	5.77	2.90	4.39	4.78
P/TBV Ratio	4.59	3.98	6.18	3.10	4.92	5.67
EV/Sales Ratio	2.93	3.18	3.18	3.34	6.62	6.41
Debt / Equity Ratio	0.87	0.75	1.45	0.86	0.45	0.91
Net Debt / Equity Ratio	0.75	0.53	1.11	0.58	0.10	0.25
Net Debt / EBITDA Ratio	8.66	-180.25	-12.52	-8.35	-2.53	-5.07
Net Debt / FCF Ratio	-2.42	-2.06	-3.15	-1.20	-0.47	-0.94
Asset Turnover	0.79	0.63	0.65	0.46	0.37	0.39
Inventory Turnover	2.05	2.08	2.86	2.67	2.83	3.59
Quick Ratio	0.55	0.74	0.81	0.79	2.02	1.71
Current Ratio	1.26	1.37	1.35	1.24	2.73	2.08
Return on Equity (ROE)	1.55%	-14.63%	-26.42%	-4.71%	-23.49%	-40.25%
Return on Assets (ROA)	0.87%	-2.69%	-5.00%	-5.59%	-5.06%	-5.38%
Return on Capital Employed (ROCE)	2.00%	-6.20%	-11.70%	-11.70%	-10.00%	-9.70%
Earnings Yield	0.36%	-3.11%	-5.29%	-1.70%	-4.86%	-4.90%
FCF Yield	-7.29%	-6.71%	-6.13%	-16.55%	-4.69%	-5.50%
Buyback Yield / Dilution	-8.40%	-19.34%	-0.34%	-21.96%	-13.03%	-25.74%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.